Paraganglioma of the head and neck long-term local control with radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 3, 2009, Pages 304-307

  Chino, Junzo P ^a   Sampson, John H ^a   Tucci, Debara L ^a   Brizel, David M ^a   Kirkpatrick, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; COBALT 60;

ACUTE TOXICITY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CATARACT; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COBALT THERAPY; DEMENTIA; DERMATITIS; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; INCIDENCE; LINEAR ACCELERATOR; LONG TERM CARE; MALE; MEGAVOLTAGE RADIATION; MUCOSA INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAGANGLIOMA; PHOTON; PHOTON THERAPY; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVERSITY HOSPITAL; VERTIGO; XEROSTOMIA;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PARAGANGLIOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67749096202     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318187dd94     Document Type: Article

References (30)

1. Larson TC III, Reese DF, Baker HL Jr, et al. Glomus tympanicum chemodectomas: radiographic and clinical characteristics. Radiology. 1987;163:801-806.
2. Manolidis S, Shohet JA, Jackson CG, et al. Malignant glomus tumors. Laryngoscope. 1999;109:30-34.
3. Jansen JC, van den Berg R, Kuiper A, et al. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88:2811-2816.
4. Carrasco V, Rosenman J. Radiation therapy of glomus jugulare tumors. Laryngoscope. 1993;103:23-27.
5. O'Leary MJ, Shelton C, Giddings NA, et al. Glomus tympanicum tumors: a clinical perspective. Laryngoscope. 1991;101:1038-1043.
6. Woods CI, Strasnick B, Jackson CG. Surgery for glomus tumors: the Otology Group experience. Laryngoscope. 1993;103:65-70.
7. Biller HF, Lawson W, Som P, et al. Glomus vagale tumors. Ann Otol Rhinol Laryngol. 1989;98:21-26.
8. Ogura JH, Spector GJ, Gado M. Glomus jugulare and vagale. Ann Otol Rhinol Laryngol. 1978;87:622-629.
9. Cole JM, Beiler D. Long-term results of treatment for glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope. 1994;104:1461- 1465.
10. Cummings BJ, Beale FA, Garrett PG, et al. The treatment of glomus tumors in the temporal bone by megavoltage radiation. Cancer. 1984;53:2635-2640.
11. Dawes PJ, Filippou M, Welch AR, et al. The management of glomus jugulare tumours. Clin Otolaryngol Allied Sci. 1987;12:15-24.
12. Fuller AM, Brown HA, Harrison EG Jr, et al. Chemodectomas of the glomus jugulare tumors. Laryngoscope. 1967;77:218-238.
13. Hinerman RW, Mendenhall WM, Amdur RJ, et al. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck. 2001;23:363-371.
14. Kim JA, Elkon D, Lim ML, et al. Optimum dose of radiotherapy for chemodectomas of the middle ear. Int J Radiat Oncol Biol Phys. 1980;6:815- 819.
15. Krych AJ, Foote RL, Brown PD, et al. Long-term results of irradiation for paraganglioma. Int J Radiat Oncol Biol Phys. 2006;65:1063-1066.
16. Powell S, Peters N, Harmer C. Chemodectoma of the head and neck: results of treatment in 84 patients. Int J Radiat Oncol Biol Phys. 1992;22:919-924.
17. Sharma PD, Johnson AP, Whitton AC. Radiotherapy for jugulo-tympanic paragangliomas (glomus jugulare tumours). J Laryngol Otol. 1984;98:621- 629.
18. Zabel A, Milker-Zabel S, Huber P, et al. Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base. Int J Radiat Oncol Biol Phys. 2004;58:1445-1450.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
21. Eustacchio S, Leber K, Trummer M, et al. Gamma knife radiosurgery for glomus jugulare tumours. Acta eurochir (Wien). 1999;141:811-818.
22. Foote RL, Coffey RJ, Gorman DA, et al. Stereotactic radiosurgery for glomus jugulare tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1997; 38:491-495.
23. Liscak R, Vladyka V, Simonova G, et al. Leksell gamma knife radiosurgery of the tumor glomus jugulare and tympanicum. Stereotact Funct Neurosurg. 1998;70(suppl 1):152-160.
24. Pollock BE. Stereotactic radiosurgery in patients with glomus jugulare tumors. Neurosurg Focus. 2004;17:E10.
25. Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol- Head Neck Surg. 2006;134:437-442.
26. Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet. 2002;39:178-183.
27. Pollard PJ, El-Bahrawy M, Poulsom R, et al. Expression of HIF-1alpha, HIF 2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab. 2006;91: 4593-4598.
28. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3: 721-732.
29. Jyung RW, LeClair EE, Bernat RA, et al. Expression of angiogenic growth factors in paragangliomas. Laryngoscope. 2000;110:161-167.
30. Brieger J, Bedavanija A, Gosepath J, et al. Vascular endothelial growth factor expression, vascularization and proliferation in paragangliomas. ORL J Otorhinolaryngol Relat Spec. 2005;67:119-124.